194 related articles for article (PubMed ID: 12778012)
21. Glioma immunology and immunotherapy.
Parney IF; Hao C; Petruk KC
Neurosurgery; 2000 Apr; 46(4):778-91; discussion 791-2. PubMed ID: 10764250
[TBL] [Abstract][Full Text] [Related]
22. Pediatric Gliomas: Current Concepts on Diagnosis, Biology, and Clinical Management.
Sturm D; Pfister SM; Jones DTW
J Clin Oncol; 2017 Jul; 35(21):2370-2377. PubMed ID: 28640698
[TBL] [Abstract][Full Text] [Related]
23. The cellular immunotherapy of primary brain tumors.
Hayes RL
Rev Neurol (Paris); 1992; 148(6-7):454-66. PubMed ID: 1448666
[TBL] [Abstract][Full Text] [Related]
24. Malignant glioma: should chemotherapy be overthrown by experimental treatments?
Hösli P; Sappino AP; de Tribolet N; Dietrich PY
Ann Oncol; 1998 Jun; 9(6):589-600. PubMed ID: 9681071
[TBL] [Abstract][Full Text] [Related]
25. Dendritic cell-based immunotherapy for malignant gliomas.
Akasaki Y; Black KL; Yu JS
Expert Rev Neurother; 2005 Jul; 5(4):497-508. PubMed ID: 16026233
[TBL] [Abstract][Full Text] [Related]
26. Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.
Chen R; Cohen AL; Colman H
Curr Treat Options Oncol; 2016 Aug; 17(8):42. PubMed ID: 27334978
[TBL] [Abstract][Full Text] [Related]
27. Precision Neuro-oncology: the Role of Genomic Testing in the Management of Adult and Pediatric Gliomas.
Ramkissoon LA; Britt N; Guevara A; Whitt E; Severson E; Sathyan P; Gay L; Elvin J; Ross JS; Brown C; Stogner-Underwood K; Mott R; Kram D; Strowd R; Lesser GJ; Ramkissoon SH
Curr Treat Options Oncol; 2018 Jun; 19(8):41. PubMed ID: 29931654
[TBL] [Abstract][Full Text] [Related]
28. Nonspecific immunotherapy with intratumoral lipopolysaccharide and zymosan A but not GM-CSF leads to an effective anti-tumor response in subcutaneous RG-2 gliomas.
Mariani CL; Rajon D; Bova FJ; Streit WJ
J Neurooncol; 2007 Dec; 85(3):231-40. PubMed ID: 17568998
[TBL] [Abstract][Full Text] [Related]
29. Radiation and Immunotherapy in High-grade Gliomas: Where Do We Stand?
Reznik E; Smith AW; Taube S; Mann J; Yondorf MZ; Parashar B; Wernicke AG
Am J Clin Oncol; 2018 Feb; 41(2):197-212. PubMed ID: 28906259
[TBL] [Abstract][Full Text] [Related]
30. Passive antibody-mediated immunotherapy for the treatment of malignant gliomas.
Mitra S; Li G; Harsh GR
Neurosurg Clin N Am; 2010 Jan; 21(1):67-76. PubMed ID: 19944967
[TBL] [Abstract][Full Text] [Related]
31. Changing paradigms for targeted therapies against diffuse infiltrative gliomas: tackling a moving target.
Carpenter CD; Alnahhas I; Gonzalez J; Giglio P; Puduvalli VK
Expert Rev Neurother; 2019 Jul; 19(7):663-677. PubMed ID: 31106606
[No Abstract] [Full Text] [Related]
32. Molecularly targeted therapy for malignant glioma.
Sathornsumetee S; Reardon DA; Desjardins A; Quinn JA; Vredenburgh JJ; Rich JN
Cancer; 2007 Jul; 110(1):13-24. PubMed ID: 17520692
[TBL] [Abstract][Full Text] [Related]
33. Novel biologic therapies for malignant gliomas. Antiangiogenesis, immunotherapy, and gene therapy.
Fine HA
Neurol Clin; 1995 Nov; 13(4):827-46. PubMed ID: 8583999
[TBL] [Abstract][Full Text] [Related]
34. [Immunotherapy of gliomas].
Kito T; Yokota A
J UOEH; 2002 Sep; 24(3):301-11. PubMed ID: 12235960
[TBL] [Abstract][Full Text] [Related]
35. Immunotherapy for malignant glioma: current approaches and future directions.
Sikorski CW; Lesniak MS
Neurol Res; 2005 Oct; 27(7):703-16. PubMed ID: 16197807
[TBL] [Abstract][Full Text] [Related]
36. Complexities, pitfalls, and strategies for evaluating brain tumor therapies.
Kaplan RS
Curr Opin Oncol; 1998 May; 10(3):175-8. PubMed ID: 9619351
[No Abstract] [Full Text] [Related]
37. Molecular therapies for malignant glioma.
Hutterer M; Gunsilius E; Stockhammer G
Wien Med Wochenschr; 2006 Jun; 156(11-12):351-63. PubMed ID: 16944367
[TBL] [Abstract][Full Text] [Related]
38. [Monoclonal immunotherapy with human monoclonal antibody(CLN-IgG) in glioma patients].
Kubo O; Takakura K
Nihon Rinsho; 2002 Mar; 60(3):497-503. PubMed ID: 11904965
[TBL] [Abstract][Full Text] [Related]
39. Animal models for vaccine therapy.
Chung DS; Kim CH; Hong YK
Adv Exp Med Biol; 2012; 746():143-50. PubMed ID: 22639165
[TBL] [Abstract][Full Text] [Related]
40. Further understanding of glioma mechanisms of pathogenesis: implications for therapeutic development.
Ruff M; Kizilbash S; Buckner J
Expert Rev Anticancer Ther; 2020 May; 20(5):355-363. PubMed ID: 32301635
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
